Usefulness of captopril renography to predict the benefits of renal artery revascularization or captopril treatment in hypertensive patients with diabetic nephropathy

Journal of Diabetes and its Complications

Volumn 16, Issue 5, 2002, Pages 344-346

  Lin, Cheng Chieh ^a   Shiau, Yu Chien ^b   Li, Tsai Chung ^c   Kao, Albert ^a   Lee, Cheng Chun ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Captopril renography; Diabetic nephropathy

Indexed keywords

CAPTOPRIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; HUMAN; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; RENAL ARTERY; RENOGRAPHY; RENOVASCULAR HYPERTENSION; RETROSPECTIVE STUDY; REVASCULARIZATION; TREATMENT OUTCOME;

AGE OF ONSET; AGED; ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CAPTOPRIL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULSE; RADIOISOTOPE RENOGRAPHY; RENAL ARTERY; VASCULAR SURGICAL PROCEDURES;

EID: 0036740901     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(02)00182-4     Document Type: Article

References (13)

1. Bakris L.G. Angiotensin-converting enzyme inhibitors and progression of diabetic nephropathy (Editorial). Annals of Internal Medicine. 118:1993;643-644.
2. Chaiwatanarat T., Padhy A.K., Bomanji J., Nimmon C.C., Sonmezoglu K., Britton K.E. Validation of renal output efficiency as an objective quantitative parameter in the evaluation of upper urinary tract obstruction. Journal of Nuclear Medicine. 34:1993;845-848.
3. Cohen J.J., Harrington J.T., Madias N.E. ACE inhibitors in renal disease. Kidney International. 42:1992;463-479.
4. Fommei E., Ghione S., Hilson A.J.W., Mezzasalma L., Oei H.Y., Piepsz A., Volterrani D. Captopril radionuclide test in renovascular hypertension: a European multicentre study. European Journal of Nuclear Medicine. 20:1993;617-623.
5. Gates G.F. Glomerular filtration rate: estimation from fractional renal accumulation of Tc-99m DTPA (stannous). AJR, American Journal of Roentgenology. 138:1982;565-570.
6. Kumar, V., Cotran, R. S., & Robbins, S. L. (Eds.) (1992). Basic pathology (5th ed.) (pp. 437-472, 569-588). Philadelphia, PA: W.B. Saunders.
7. Mann S.J., Pickering T.G. Detection of renovascular hypertension. State of the art: 1992. Annals of Internal Medicine. 117:1992;845-853.
8. Nally I.V., Black H.R. State-of-the-art review: captopril renography - pathophysiological considerations and clinical observations. Seminars in Nuclear Medicine. 22:1992;85-97.
9. National Health Department, Taiwan (1977). Annual Vital Statistics.
10. National Health Department, Taiwan (2000). Annual Vital Statistics.
11. National Health Insurance Bureau, Taiwan (1998). Statistics Report.
12. Taylor A.T. Jr., Fletcher J.W., Nally J.V. Jr., Blaufox M.D., Dubovsky E.V., Fine E.J. Procedure guideline for diagnosis of renovascular hypertension. Journal of Nuclear Medicine. 39:1998;1297-1302.
13. Valabhji J., Robinson S., Poulter C., Robinson A.C., Kong C., Henzen C., Gedroyc W.M., Feher M.D., Elkeles R.S. Prevalence of renal artery stenosis in subjects with Type 2 diabetes and coexistent hypertension. Diabetes Care. 23:2000;539-543.